Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sesame Care vs Direct Meds

Two GLP-1 desks, one scoreboard. We put Sesame Care and Direct Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 4 · Grade B+

Sesame Care

Visit Sesame Care Full brief →
vs
No. 30 · Grade B−

Direct Meds

Visit Direct Meds Full brief →

FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.

The verdict

Sesame Care takes this head-to-head.

Sesame Care scores 87 to 82 on our six-factor Brief Score — An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

That doesn't make Direct Meds a bad call — it's best for readers who want a needle-free oral or sublingual route on either molecule and an all-inclusive price with no separate membership — and who are comfortable that the figures are company-stated rather than checkout-verified. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
84
80
Supply Reliability
92
80
Transparency
94
78
Access Breadth
84
84
Clinical Oversight
80
83
Track Record
92
78
Sesame CareBrief Score 87 · 82Direct Meds

Price, coverage & the tracker

Sesame CareDirect Meds
Brief Score87/100 (B+)82/100 (B−)
SemaglutideCare $59/mo only on the 12-month prepay ($708 in one charge), $69/mo on 6 months, $79/mo on 3 months, otherwise $99 billed every 28 days (13 charges a year) — plus the drug: brand Wegovy pill from $149/mo at 1.5 and 4 mg only, $299/mo at 9 and 25 mg$249/mo sublingual · $297/mo injectable — both billed monthly on a 3-month minimum commitment
TirzepatideCare $59/mo only on the 12-month prepay, $69/mo on 6 months, $79/mo on 3 months, otherwise $99 per 28 days — plus the drug: brand Zepbound vial $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg); KwikPen $299 / $399 / $499 / $699 (10–15 mg)$299/mo sublingual · $399/mo injectable — both billed monthly on a 3-month minimum commitment
CoverageNationwide marketplaceNot publicly listed
Brand-name accessYesCompounded only
Oral / sublingualYesYes
On the trackerStableprice stableStableprice stable

Sesame Care: Marketplace pricing is set per provider rather than one provider rate; the brand-name Wegovy pill line held its ~$149 entry this cycle.

Direct Meds: Company-stated rates unchanged this cycle — but we price these off the provider's own listings, not a live-verified checkout, so treat them as indicative.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.